Skip to main content
Have a personal or library account? Click to login
The Use of High Dose Eltrombopag in the Management of Sepsis-Associated Thrombocytopenia in Critically Ill Patients Cover

The Use of High Dose Eltrombopag in the Management of Sepsis-Associated Thrombocytopenia in Critically Ill Patients

The Journal of Critical Care Medicine
Volume 5 (2019): Issue 4 (October 2019)
By: ,   and    
Open Access
|Nov 2019
Authors

Authors

Md. Jahidul Hasan

jahidrj@gmail.com

Department of Clinical Pharmacy, Square Hospitals Ltd, Dhaka, Bangladesh

Raihan Rabbani

Internal Medicine and ICU, Square Hospitals Ltd, Dhaka, Bangladesh

Shihan Mahmud Redwanul Huq

Internal Medicine and ICU, Square Hospitals Ltd, Dhaka, Bangladesh
DOI: https://doi.org/10.2478/jccm-2019-0019 | Journal eISSN: 2393-1817 | Journal ISSN: 2393-1809
Journal RSS Feed
Language: English
Page range: 123 - 129
Submitted on: May 15, 2019
Accepted on: Aug 5, 2019
Published on: Nov 27, 2019
Published by: University of Medicine, Pharmacy, Science and Technology of Targu Mures
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Eltrombopag,
sepsis,
thrombocytopenia,
megakaryocytes,
thrombopoietin receptor
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Internal medicine, other,
Surgery,
Surgery, other,
Anaesthesiology,
Emergency medicine and intensive-care medicine

© 2019 Md. Jahidul Hasan, Raihan Rabbani, Shihan Mahmud Redwanul Huq, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Volume 5 (2019): Issue 4 (October 2019)
Next article